Skip to main content
Premium Trial:

Request an Annual Quote

InformedDNA Nabs $4.5M Investment

NEW YORK (GenomeWeb) – Genetics services firm InformedDNA today said that it has reached a $4.5 million funding agreement with Blue Cross Blue Shield of Massachusetts' wholly owned subsidiary Zaffre Investments.

InformedDNA will use the funds to expand its use of information technology in order to improve the efficiency and capacity of its genetics benefits utilization management capabilities. The company added that the investment also will go toward the management of its rapid growth.

"InformedDNA will be able to serve patients more quickly while improving care quality and preventing waste and excess costs," the company's CEO David Nixon said in a statement. Among the products and services the company provides are clinical genetic counseling, genetic testing utilization management, and personalized hereditary risk assessment and prevention solutions.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.